Rocket Pharmaceuticals (RCKT) Earnings Date, Estimates & Call Transcripts $20.17 -1.19 (-5.57%) (As of 09/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Aug. 5) -$0.74 Missed By -$0.02 Consensus EPS (Aug. 5) -$0.72 Conference Call TranscriptConference Call AudioEarnings Press Release Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRCKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCKT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. Rocket Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.70)($0.49)($0.60)Q2 20243($0.80)($0.69)($0.73)Q3 20243($0.81)($0.43)($0.67)Q4 20243($0.83)$0.08($0.51)FY 202411($3.14)($1.53)($2.52)Q1 20251($0.84)($0.84)($0.84)Q2 20251($0.79)($0.79)($0.79)Q3 20251($0.81)($0.81)($0.81)Q4 20251($0.77)($0.77)($0.77)FY 20254($3.21)($3.21)($3.21)RCKT Earnings Date and InformationRocket Pharmaceuticals last posted its quarterly earnings results on August 5th, 2024. The biotechnology company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.72) by $0.02. Rocket Pharmaceuticals has generated ($2.87) earnings per share over the last year (($2.87) diluted earnings per share). Earnings for Rocket Pharmaceuticals are expected to grow in the coming year, from ($2.97) to ($2.42) per share. Rocket Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More Rocket Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 8/5/2024Q2 2024($0.72)($0.74)($0.02)($0.74)-- 5/6/2024Q1 2024($0.67)($0.66)+$0.01($0.66)-- 2/26/2024Q4 2023($0.78)($0.64)+$0.14($0.64)-- 11/6/2023Q3 2023($0.81)($0.75)+$0.06($0.75)-- 8/10/2023Q2 2023($0.81)($0.82)($0.01)($0.82)-- 5/4/2023Q1 2023($0.84)($0.73)+$0.11($0.73)-- Billionaires Are Betting Big on “Nexus” Technology (Ad)TWO firms are already on track to crack the trillion-dollar mark because of this technology. But here's the kicker: I've discovered an under-the-radar play that's currently trading for only $8.Click here for our #1 "Retirement Window" Stock >>>2/27/2023Q4 2022($0.82)($0.92)($0.10)($0.92)--11/3/2022Q3 2022($0.77)($0.87)($0.10)($0.87)--8/8/2022Q2 2022($0.68)($0.83)($0.15)($0.83)--5/5/2022Q1 2022($0.70)($0.67)+$0.03($0.67)--2/24/2022Q4 2021($0.75)($0.69)+$0.06($0.69)-- 11/3/2021Q3 2021($0.60)($0.79)($0.19)($0.79)--8/9/2021Q2 2021($0.66)($0.55)+$0.11($0.55)-- 5/10/2021Q1 2021($0.69)($0.65)+$0.04($0.65)--2/25/2021Q4 2020($0.52)($1.08)($0.56)($1.08)--11/4/2020Q3 2020($0.45)($0.53)($0.08)($0.53)--8/5/2020Q2 2020($0.50)($0.45)+$0.05($0.45)--5/6/2020Q1 2020($0.48)($0.45)+$0.03($0.45)--3/5/2020Q4 2019($0.49)($0.39)+$0.10($0.39)--11/7/2019Q3($0.4920)($0.38)+$0.1120($0.38)-- Rocket Pharmaceuticals Earnings - Frequently Asked Questions When is Rocket Pharmaceuticals's earnings date? Rocket Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on RCKT's earnings history. Did Rocket Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rocket Pharmaceuticals (NASDAQ:RCKT) missed the analysts' consensus estimate of ($0.72) by $0.02 with a reported earnings per share (EPS) of ($0.74). Learn more on analysts' earnings estimate vs. RCKT's actual earnings. How can I listen to Rocket Pharmaceuticals's earnings conference call? The conference call for Rocket Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Rocket Pharmaceuticals's conference call transcript? The conference call transcript for Rocket Pharmaceuticals's latest earnings report can be read online. Read Transcript How much profit does Rocket Pharmaceuticals generate each year? Rocket Pharmaceuticals (NASDAQ:RCKT) has a recorded net income of -$245.60 million. RCKT has generated -$2.87 earnings per share over the last four quarters. What is Rocket Pharmaceuticals's EPS forecast for next year? Rocket Pharmaceuticals's earnings are expected to grow from ($2.97) per share to ($2.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Arcus Biosciences Earnings Results Aurinia Pharmaceuticals Earnings Results Y-mAbs Therapeutics Earnings Results Heron Therapeutics Earnings Results Mersana Therapeutics Earnings Results Amarin Earnings Results Generation Bio Earnings Results NGM Biopharmaceuticals Earnings Results Madrigal Pharmaceuticals Earnings Results Elanco Animal Health Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:RCKT) was last updated on 9/21/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWar on Elon Escalates… One company holds a near-total monopoly on this technology. Elon Musk is one of the few people who knows th...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredGenerational Opportunities in the 4th Industrial RevolutionThe industrial revolutions in our country's past have connected the world in ways never thought possible… C...Unstoppable Prosperity | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Rocket Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
